Amgen vs Bank of America: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: Amgen and Bank of America side by side

1. 1904Bank of America

   Bank of Italy Founded

   A.P. Giannini founded the Bank of Italy in San Francisco to expand access to banking for immigrants, wage earners, and small merchants.

2. 1906Bank of America

   San Francisco Earthquake Response

   After the 1906 earthquake, Giannini resumed lending while much of San Francisco's banking system was disrupted. The response turned emergency access to credit into lasting customer trust and became a defining story in the bank's retail identity.

3. 1930Bank of America

   Bank of Italy Renamed Bank of America

   The Bank of Italy changed its name to Bank of America on November 1, 1930. The rebrand reflected a wider consumer and business ambition beyond the original immigrant-community label.

4. 1958Bank of America

   BankAmericard Introduced

   Bank of America introduced BankAmericard in 1958, a revolving-credit card that later became part of the Visa system. The product tied the bank to modern consumer credit, merchant acceptance, and payment-network economics.

5. 1980Amgen

   Applied Molecular Genetics is incorporated

   Applied Molecular Genetics (AMGen) was incorporated on April 8, 1980 in Thousand Oaks, California, as the idea of venture capitalist William K. Bowes Jr. and a group of scientific collaborators.

6. 1983Amgen

   Nasdaq listing and the erythropoietin clone

   Amgen completed its initial public offering on June 17, 1983, raising nearly US$40 million under chief financial officer Gordon Binder, and formally shortened its name to Amgen.

7. 1984Amgen

   Kirin-Amgen joint venture formed

   Amgen and Kirin Brewery Company of Japan formed Kirin-Amgen in 1984 as a joint venture for the worldwide commercialization of erythropoietin.

8. 1985Amgen

   G-CSF cloned, leading to Neupogen

   While Fu-Kuen Lin's team worked on erythropoietin, researcher Larry Souza and his group cloned and expressed human granulocyte colony-stimulating factor in 1985.

9. 1989Amgen

   FDA approves Epogen

   The FDA approved Epogen (epoetin alfa) on June 1, 1989 for anemia in patients with chronic kidney failure on dialysis. It was the first commercial recombinant human erythropoietin. Epogen's U.S.

10. 1991Amgen

    Neupogen approved, giving Amgen a second franchise

    The FDA approved Neupogen (filgrastim) in February 1991. By stimulating white blood cell production it reduced the risk of infection in cancer patients with chemotherapy-induced neutropenia.

11. 1991Amgen

    Amgen wins the erythropoietin patent fight

    On March 6, 1991 the U.S. Court of Appeals for the Federal Circuit upheld the Kirin-Amgen erythropoietin patent and ruled against Genetics Institute in Amgen v. Chugai Pharmaceutical and Genetics Institute.

12. 1998Bank of America

    NationsBank and BankAmerica Merge

    The 1998 merger of Charlotte-based NationsBank and San Francisco's BankAmerica created the first coast-to-coast U.S. bank under the Bank of America name. It also shifted the modern company's headquarters center to Charlotte.

13. 2001Amgen

    FDA approves Aranesp, the longer-acting EPO

    Aranesp (darbepoetin alfa), an erythropoietin analogue with modified glycosylation and a longer half-life, was approved in 2001. Less frequent dosing than Epogen improved convenience and gave Amgen a newer, higher-priced product to migrate patients toward.

14. 2002Amgen

    US$16 billion Immunex acquisition brings Enbrel in-house

    Amgen completed its acquisition of Immunex Corporation on July 16, 2002, the largest biotechnology deal to that point at about US$16 billion in stock and cash.

15. 2006Bank of America

    MBNA Merger Completed

    The MBNA merger expanded the card business to more than 40M active accounts and nearly $140B in managed balances, according to the company's January 2006 release. That size made cards a more important part of consumer banking revenue and risk.

16. 2008Bank of America

    Countrywide Acquisition Approved

    The Federal Reserve approved Bank of America's acquisition of Countrywide in June 2008. The deal added mortgage scale but later became a costly warning about buying distressed loan portfolios during a housing crisis.

17. 2008Bank of America

    Merrill Lynch Acquisition Approved

    The Federal Reserve approved the acquisition of Merrill Lynch in November 2008. Although the integration was controversial, Merrill became central to the company's wealth-management and investment-banking fee base.

18. 2010Amgen

    Prolia and XGEVA create the bone health franchise

    The FDA approved Prolia (denosumab) for postmenopausal osteoporosis in June 2010 and XGEVA, the same molecule at a higher dose, for prevention of skeletal-related events in cancer patients in November 2010.

19. 2014Bank of America

    Mortgage Settlements With the Justice Department and FHFA

    Bank of America agreed in August 2014 to a $16.65B settlement with the Justice Department over mortgage claims tied to Countrywide and Merrill Lynch, following a March 2014 FHFA agreement with an aggregate payment of about $9.33B.

20. 2018Bank of America

    Erica Launched

    Bank of America launched Erica in 2018 as an AI-enabled virtual assistant inside digital banking. The launch mattered because customer service, insights, and routine account tasks were moving from branches and call centers into mobile channels.

21. 2019Amgen

    US$13.4 billion purchase of Otezla from Celgene

    Amgen agreed in August 2019 to buy worldwide rights to Otezla (apremilast) from Celgene for US$13.4 billion in cash, or about US$11.2 billion net of the present value of US$2.2 billion of anticipated future cash tax benefits, and closed on November 21, 2019.

22. 2020Amgen

    Amgen joins the Dow Jones Industrial Average

    Amgen replaced Pfizer in the Dow Jones Industrial Average on August 31, 2020, becoming one of the thirty components in the index. Inclusion recognized the scale Amgen had reached and added passive demand from Dow-tracking funds.

23. 2023Amgen

    US$27.8 billion Horizon Therapeutics acquisition closes

    Amgen completed the acquisition of Horizon Therapeutics plc on October 6, 2023 for US$116.50 per share in cash, an equity value of about US$27.8 billion, after settling FTC litigation with a behavioral consent decree.

24. 2023Bank of America

    CFPB and OCC Orders on Fees, Rewards and Accounts

    In July 2023 the CFPB ordered Bank of America to pay more than $100M to customers for repeat non-sufficient-funds fees, withheld credit card rewards and unauthorized accounts, plus $90M in CFPB penalties, and the OCC added a $60M penalty.

25. 2024Amgen

    Imdelltra becomes the first T-cell engager for small cell lung cancer

    The FDA granted accelerated approval to tarlatamab, sold as Imdelltra, on May 16, 2024 for extensive stage small cell lung cancer that has progressed on or after platinum-based chemotherapy.

26. 2025Amgen

    VESALIUS-CV extends the Repatha case to primary prevention

    In November 2025 Amgen reported Phase 3 VESALIUS-CV results in more than 12,000 patients with atherosclerosis or diabetes but no prior heart attack or stroke.

27. 2025Bank of America

    $113.1B FY2025 Revenue

    The company reported $113.1B in total revenue net of interest expense and $30.5B in net income for FY2025. The result showed the combined scale of deposits, wealth management, cards, payments, global banking, and markets.

28. 2025Bank of America

    Co-Presidents Named

    On September 12, 2025 Bank of America named Dean Athanasia and Jim DeMare Co-Presidents and gave Chief Financial Officer Alastair Borthwick the added title of executive vice president.

29. 2026Amgen

    Medicare price setting reaches Enbrel and Otezla

    Enbrel's negotiated Medicare price under the Inflation Reduction Act took effect on January 1, 2026, after it was named in the first round of ten drugs selected for negotiation.

Acquisitions

Questions about Amgen vs Bank of America